Dissecting the indirect effects caused by vaccines into the basic elements

References

• Kim TH, Johnstone J, Loeb M. Vaccine herd effect. Scand J Infect Dis 2011; 43: 683-9; PMID:21604922
   PubMed Web of Science ®Google Scholar
• Brisson M, Edmunds WJ. Economic evaluation of vaccination programs: the impact of herd-immunity. Med Decis Making 2003; 23: 76-82; PMID:12583457; http://dx.doi.org/10.1177/0272989X02239651
   PubMed Web of Science ®Google Scholar
• Kim SY, Goldie SJ. Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches. Pharmacoeconomics 2008; 26: 191-215; PMID:18282015; http://dx.doi.org/10.2165/00019053-200826030-00004
   PubMed Web of Science ®Google Scholar
• Jit M, Newall AT, Beutels P. Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies. Hum Vaccin Immunother 2013; 9: 834-40; PMID:23357859; http://dx.doi.org/10.4161/hv.23637
   PubMed Web of Science ®Google Scholar
• Boulier BL, Tejwant SD, Goldfarb RS. Vaccination Externalities. The B.E. Journal of Economic Analysis and Policy 2007; 7; http://dx.doi.org/10.2202/1935-1682.1487
   Web of Science ®Google Scholar
• Plans-Rubio P. Evaluation of the establishment of herd immunity in the population by means of serological surveys and vaccination coverage. Hum Vaccin Immunother 2012; 8: 184-8; PMID:22426372; http://dx.doi.org/10.4161/hv.18444
   PubMed Web of Science ®Google Scholar
• Clemens J, Shin S, Ali M. New approaches to the assessment of vaccine herd protection in clinical trials. Lancet Infect Dis 2011; 11: 482-7; PMID:21616458; http://dx.doi.org/10.1016/S1473-3099(10)70318-2
   PubMed Web of Science ®Google Scholar
• Smith PG. Concepts of herd protection and immunity. Ninth Global Vaccine Research Forum and Parallel Satellite Symposia; 2009 December 6–9 Bamako, Mali; Keppel Street, London WCIE 7HT, United Kingdom. Procedia Vaccinol 2; 2010. 134-9; http://dx.doi.org/10.1016/j.provac.2010.07.005
   Google Scholar
• Jit M, Brisson M. Modelling the epidemiology of infectious diseases for decision analysis: a primer. Pharmacoeconomics 2011; 29: 371-86; PMID:21504239; http://dx.doi.org/10.2165/11539960-000000000-00000
   PubMed Web of Science ®Google Scholar
• Beutels P, Van Doorslaer E, Van Damme P, Hall J. Methodological issues and new developments in the economic evaluation of vaccines. Expert Rev Vaccines 2003; 2: 649-60; PMID:14711326; http://dx.doi.org/10.1586/14760584.2.5.649
   PubMedGoogle Scholar
• Donaghy M, Cameron JC, Friederichs V. Increasing incidence of mumps in Scotland: options for reducing transmission. J Clin Virol 2006; 35: 121-9; PMID:16289903; http://dx.doi.org/10.1016/j.jcv.2005.09.009
   PubMed Web of Science ®Google Scholar
• Edmunds WJ, Medley GF, Nokes DJ. Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective. Stat Med 1999; 18: 3263-82; PMID:10602150; http://dx.doi.org/10.1002/(SICI)1097-0258(19991215)18:23%3c3263::AID-SIM315%3e3.0.CO;2-3
   PubMed Web of Science ®Google Scholar
• Vynnycky E, White R. An Introduction to Infectious Disease Modelling. Great Clarendon Street, Oxford 0´2 6DP: Oxford University Press; 2011. Section 1.3: Transmission; p. 5-7
   Google Scholar
• Fine P, Eames K, Heymann DL. “Herd immunity:” a rough guide. Clin Infect Dis 2011; 52: 911-6; PMID:21427399; http://dx.doi.org/10.1093/cid/cir007
   PubMed Web of Science ®Google Scholar
• Pitman R, Fisman D, Zaric GS, Postma M, Kretzschmar M, Edmunds J, Brisson M. Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force–5. Value Health 2012; 15: 828-34; PMID:22999132; http://dx.doi.org/10.1016/j.jval.2012.06.011
   PubMed Web of Science ®Google Scholar
• Garnett GP. Role of herd immunity in determining the effect of vaccines against sexually transmitted disease. J Infect Dis 2005; 191 Suppl 1: S97-106; PMID:15627236; http://dx.doi.org/10.1086/425271
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of vaccines and immune globulins in persons with altered immunocompetence. MMWR 1993; 42 (No. RR-5):[inclusive page numbers].
   Google Scholar
• Moss W, Lederman H. Immunization of the immunocompromised host. Clin Focus Immune Deficiencies: Issues Information Curr Topics 1998; 1: 1-8
   Google Scholar
• Walker D, Beutels P. WHO guide for standardization of economic evaluations of immunization programmes. CH-1211 Geneva 27, Switzerland: World Health Organization, Department of Immunization, Vaccin Biol; 2008. 100 p. Report No.: WHO/IVB/08.14. Initiative for Vaccine Research (IVR)
   Google Scholar
• Bauch CT, Anonychuk AM, Van Effelterre T, Pham BZ, Merid MF. Incorporating herd immunity effects into cohort models of vaccine cost-effectiveness. Med Decis Making 2009; 29: 557-69; PMID:19605882; http://dx.doi.org/10.1177/0272989X09334419
   PubMed Web of Science ®Google Scholar
• Van Vlaenderen I, Van Bellinghen LA, Meier G, Nautrup BP. An approximation of herd effect due to vaccinating children against seasonal influenza - a potential solution to the incorporation of indirect effects into static models. BMC Infect Dis 2013; 13: 25; PMID:23339290; http://dx.doi.org/10.1186/1471-2334-13-25
   PubMed Web of Science ®Google Scholar
• Bos JM, Alphen L, Postma MJ. The use of modeling in the economic evaluation of vaccines. Expert Rev Pharmacoecon Outcomes Res 2002; 2: 443-55; PMID:19807468; http://dx.doi.org/10.1586/14737167.2.5.443
   PubMedGoogle Scholar
• Trotter CL, Maiden MC. Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Rev Vaccines 2009; 8: 851-61; PMID:19538112; http://dx.doi.org/10.1586/erv.09.48
   PubMed Web of Science ®Google Scholar
• Van Effelterre T, Soriano-Gabarro M, Debrus S, Claire Newbern E, Gray J. A mathematical model of the indirect effects of rotavirus vaccination. Epidemiol Infect 2009; 138: 884-97; PMID:20028612; http://dx.doi.org/10.1017/S0950268809991245
   PubMed Web of Science ®Google Scholar
• Rashid H, Khandaker G, Booy R. Vaccination and herd immunity: what more do we know? Curr Opin Infect Dis 2012; 25: 243-9; PMID:22561998; http://dx.doi.org/10.1097/QCO.0b013e328352f727
   PubMed Web of Science ®Google Scholar
• Halloran ME, Struchiner CJ, Longini IM, Jr. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. Am J Epidemiol 1997; 146: 789-803; PMID:9384199; http://dx.doi.org/10.1093/oxfordjournals.aje.a009196
   PubMed Web of Science ®Google Scholar
• Samandari T, Bell BP, Armstrong GL. Quantifying the impact of hepatitis A immunization in the United States, 1995–2001. Vaccine 2004; 22: 4342-50; PMID:15474727; http://dx.doi.org/10.1016/j.vaccine.2004.04.014
   PubMed Web of Science ®Google Scholar
• Wenger JD. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada. Pediatr Infect Dis J 1998; 17: S132-6; PMID:9781746; http://dx.doi.org/10.1097/00006454-199809001-00008
   PubMed Web of Science ®Google Scholar
• Trollfors B, Taranger J, Lagergard T, Sundh V, Bryla DA, Schneerson R, Robbins JB. Immunization of children with pertussis toxoid decreases spread of pertussis within the family. Pediatr Infect Dis J 1998; 17: 196-9; PMID:9535245; http://dx.doi.org/10.1097/00006454-199803000-00005
   PubMed Web of Science ®Google Scholar
• Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, Harrison LH, Schaffner W, Reingold A, Bennett NM, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. Jama 2005; 294: 2043-51; PMID:16249418; http://dx.doi.org/10.1001/jama.294.16.2043
   PubMed Web of Science ®Google Scholar
• Raes M, Strens D, Vergison A, Verghote M, Standaert B. Reduction in pediatric rotavirus-related hospitalizations after universal rotavirus vaccination in Belgium. Pediatr Infect Dis J 2011; 30: e120-5; PMID:21436757; http://dx.doi.org/10.1097/INF.0b013e318214b811
   PubMed Web of Science ®Google Scholar
• Berndsen MR, Erlendsdottir H, Gottfredsson M. Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study. Clin Microbiol Infect 2011; 18: 918-23; PMID:22070637; http://dx.doi.org/10.1111/j.1469-0691.2011.03700.x
   PubMed Web of Science ®Google Scholar
• Adam HJ, Richardson SE, Jamieson FB, Rawte P, Low DE, Fisman DN. Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination. Vaccine 2010; 28: 4073-8; PMID:20398617; http://dx.doi.org/10.1016/j.vaccine.2010.03.075
   PubMed Web of Science ®Google Scholar
• Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348: 1737-46; PMID:12724479; http://dx.doi.org/10.1056/NEJMoa022823
   PubMed Web of Science ®Google Scholar
• Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS, Farley MM, Jorgensen JH, Lexau CA, Petit S, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 2009; 360: 244-56; PMID:19144940; http://dx.doi.org/10.1056/NEJMoa0800836
   PubMed Web of Science ®Google Scholar
• Ramsay ME, Andrews NJ, Trotter CL, Kaczmarski EB, Miller E. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. Bmj 2003; 326: 365-6; PMID:12586669; http://dx.doi.org/10.1136/bmj.326.7385.365
   PubMed Web of Science ®Google Scholar
• Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 2011; 11: 760-8; PMID:21621466; http://dx.doi.org/10.1016/S1473-3099(11)70090-1
   PubMed Web of Science ®Google Scholar
• Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease–United States, 1998–2003. MMWR Morb Mortal Wkly Rep 2005; 54(36): 893-7; PMID:16163262
   PubMedGoogle Scholar
• Paulke-Korinek M, Kundi M, Rendi-Wagner P, de Martin A, Eder G, Schmidle-Loss B, Vecsei A, Kollaritsch H. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. Vaccine 2011; 29: 2791-6; PMID:21320539; http://dx.doi.org/10.1016/j.vaccine.2011.01.104
   PubMed Web of Science ®Google Scholar
• Fitzwater SP, Chandran A, Santosham M, Johnson HL. The worldwide impact of the seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2012; 31: 501-8; PMID:22327872; http://dx.doi.org/10.1097/INF.0b013e31824de9f6
   PubMed Web of Science ®Google Scholar
• Dominguez A, Oviedo M, Carmona G, Batalla J, Bruguera M, Salleras L, Plasencia A. Impact and effectiveness of a mass hepatitis A vaccination programme of preadolescents seven years after introduction. Vaccine 2008; 26: 1737-41; PMID:18325642; http://dx.doi.org/10.1016/j.vaccine.2008.01.048
   PubMed Web of Science ®Google Scholar
• Ong G, Hoon HB, Ong A, Chua LT, Kai CS, Tai GK. A 24-year review on the epidemiology and control of measles in Singapore, 1981–2004. Southeast Asian J Trop Med Public Health 2006; 37: 96-101; PMID:16771219
   PubMedGoogle Scholar
• Payne DC, Staat MA, Edwards KM, Szilagyi PG, Weinberg GA, Hall CB, Chappell J, Curns AT, Wikswo M, Tate JE, et al. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006–2009. Clin Infect Dis 2011; 53: 245-53; PMID:21705316; http://dx.doi.org/10.1093/cid/cir307
   PubMed Web of Science ®Google Scholar
• Zlamy M, Kofler S, Orth D, Wurzner R, Heinz-Erian P, Streng A, Prelog M. The impact of Rotavirus mass vaccination on hospitalization rates, nosocomial Rotavirus gastroenteritis and secondary blood stream infections. BMC Infect Dis 2013; 13: 112; PMID:23452879; http://dx.doi.org/10.1186/1471-2334-13-112
   PubMed Web of Science ®Google Scholar
• Gil E, Noursadeghi M, Brown JS. The clinical and ecological impact of childhood pneumococcal vaccination. Br J Hosp Med (Lond) 2013; 74: 212-6; PMID:23571392; http://dx.doi.org/10.12968/hmed.2013.74.4.212
   PubMed Web of Science ®Google Scholar
• Wasley A, Samandari T, Bell BP. Incidence of hepatitis A in the United States in the era of vaccination. Jama 2005; 294: 194-201; PMID:16014593; http://dx.doi.org/10.1001/jama.294.2.194
   PubMed Web of Science ®Google Scholar
• Armstrong GL, Billah K, Rein DB, Hicks KA, Wirth KE, Bell BP. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity. Pediatrics 2007; 119: e22-9; PMID:17200247; http://dx.doi.org/10.1542/peds.2006-1572
   PubMed Web of Science ®Google Scholar
• Lenne X, Diez Domingo J, Gil A, Ridao M, Lluch JA, Dervaux B. Economic evaluation of varicella vaccination in Spain: results from a dynamic model. Vaccine 2006; 24: 6980-9; PMID:16860909; http://dx.doi.org/10.1016/j.vaccine.2006.04.051
   PubMed Web of Science ®Google Scholar
• Streng A, Grote V, Carr D, Hagemann C, Liese JG. Varicella routine vaccination and the effects on varicella epidemiology - results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006–2011. BMC Infect Dis 2013; 13: 303; PMID:23815523; http://dx.doi.org/10.1186/1471-2334-13-303
   PubMed Web of Science ®Google Scholar
• Guris D, Jumaan AO, Mascola L, Watson BM, Zhang JX, Chaves SS, Gargiullo P, Perella D, Civen R, Seward JF. Changing varicella epidemiology in active surveillance sites–United States, 1995–2005. J Infect Dis 2008; 197 Suppl 2: S71-5; PMID:18419413; http://dx.doi.org/10.1086/522156
   PubMed Web of Science ®Google Scholar
• Dagan R, Leventhal A, Anis E, Slater P, Ashur Y, Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. Jama 2005; 294: 202-10; PMID:16014594; http://dx.doi.org/10.1001/jama.294.2.202
   PubMed Web of Science ®Google Scholar
• Broker M. Indirect effects by meningococcal vaccines: herd protection versus herd immunity. Hum Vaccin 2011; 7: 881-2; PMID:21785283; http://dx.doi.org/10.4161/hv.7.8.16273
   PubMed Web of Science ®Google Scholar
• Goncalves G. Herd immunity: recent uses in vaccine assessment. Expert Rev Vaccines 2008; 7: 1493-506; PMID:19053206; http://dx.doi.org/10.1586/14760584.7.10.1493
   PubMed Web of Science ®Google Scholar
• Brisson M, van de Velde N, Franco EL, Drolet M, Boily MC. Incremental impact of adding boys to current human papillomavirus vaccination programs: role of herd immunity. J Infect Dis 2011; 204: 372-6; PMID:21742835; http://dx.doi.org/10.1093/infdis/jir285
   PubMed Web of Science ®Google Scholar
• Arinaminpathy N, Lavine JS, Grenfell BT. Self-boosting vaccines and their implications for herd immunity. Proc Natl Acad Sci U S A 2012; 109: 20154-9; PMID:23169630; http://dx.doi.org/10.1073/pnas.1209683109
   PubMed Web of Science ®Google Scholar
• Coudeville L, Van Rie A, Getsios D, Caro JJ, Crepey P, Nguyen VH. Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects. PLoS One 2009; 4: e6284; PMID:19606227; http://dx.doi.org/10.1371/journal.pone.0006284
   PubMed Web of Science ®Google Scholar
• Burns DL, Meade BD, Messionnier NE. Pertussis resurgence: perspectives from the Working Group Meeting on pertussis on the causes, possible paths forward, and gaps in our knowledge. J Infect Dis 2014; 209 Suppl 1: S32-5; PMID:24626870; http://dx.doi.org/10.1093/infdis/jit491
   PubMed Web of Science ®Google Scholar
• Aguas R, Goncalves G, Gomes MG. Pertussis: increasing disease as a consequence of reducing transmission. Lancet Infect Dis 2006; 6: 112-7; PMID:16439331; http://dx.doi.org/10.1016/S1473-3099(06)70384-X
   PubMed Web of Science ®Google Scholar
• Broutin H, Viboud C, Grenfell BT, Miller MA, Rohani P. Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries. Proc Biol Sci 2010; 277: 3239-45; PMID:20534609; http://dx.doi.org/10.1098/rspb.2010.0994
   PubMed Web of Science ®Google Scholar
• Guris D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, Wharton M, Livengood JR. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990–1996. Clin Infect Dis 1999; 28: 1230-7; PMID:10451158; http://dx.doi.org/10.1086/514776
   PubMed Web of Science ®Google Scholar
• Trotter CL, Edmunds WJ. Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model. Med Decis Making 2006; 26: 38-47; PMID:16495199; http://dx.doi.org/10.1177/0272989X05284109
   PubMed Web of Science ®Google Scholar
• de Vries R, Kretzschmar M, Schellekens JF, Versteegh FG, Westra TA, Roord JJ, Postma MJ. Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model. PLoS One 2010; 5: e13392; PMID:20976213; http://dx.doi.org/10.1371/journal.pone.0013392
   PubMed Web of Science ®Google Scholar
• Lopalco PL, Salleras L, Barbuti S, Germinario C, Bruguera M, Buti M, Dominguez A. Hepatitis A and B in children and adolescents–what can we learn from Puglia (Italy) and Catalonia (Spain)? Vaccine 2001; 19: 470-4; http://dx.doi.org/10.1016/S0264-410X(00)00193-6
   Web of Science ®Google Scholar
• Bielicki JA, Achermann R, Berger C. Timing of measles immunization and effective population vaccine coverage. Pediatrics 2012; 130: e600-6; PMID:22908102; http://dx.doi.org/10.1542/peds.2012-0132
   PubMedGoogle Scholar
• Atkinson WL, Orenstein WA, Krugman S. The resurgence of measles in the United States, 1989–1990. Annu Rev Med 1992; 43: 451-63; PMID:1580601; http://dx.doi.org/10.1146/annurev.me.43.020192.002315
   PubMed Web of Science ®Google Scholar
• Postma MJ, Westra TA, Quilici S, Largeron N. Economic evaluation of vaccines: specificities and future challenges illustrated by recent European examples. Expert Rev Vaccines 2013; 12: 555-65; PMID:23659302; http://dx.doi.org/10.1586/erv.13.36
   PubMed Web of Science ®Google Scholar
• Panagiotopoulos T, Antoniadou I, Valassi-Adam E. Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review. Bmj 1999; 319: 1462-7; PMID:10582926; http://dx.doi.org/10.1136/bmj.319.7223.1462
   PubMed Web of Science ®Google Scholar
• Bogaards JA, Coupe VM, Xiridou M, Meijer CJ, Wallinga J, Berkhof J. Long-term impact of human papillomavirus vaccination on infection rates, cervical abnormalities, and cancer incidence. Epidemiology 2011; 22: 505-15; PMID:21540743; http://dx.doi.org/10.1097/EDE.0b013e31821d107b
   PubMed Web of Science ®Google Scholar
• Salathe M, Bonhoeffer S. The effect of opinion clustering on disease outbreaks. J R Soc Interface 2008; 5: 1505-8; PMID:18713723; http://dx.doi.org/10.1098/rsif.2008.0271
   PubMedGoogle Scholar
• Dallaire F, De Serres G, Tremblay FW, Markowski F, Tipples G. Long-lasting measles outbreak affecting several unrelated networks of unvaccinated persons. J Infect Dis 2009; 200: 1602-5; PMID:19827945; http://dx.doi.org/10.1086/644783
   PubMed Web of Science ®Google Scholar
• Sugerman DE, Barskey AE, Delea MG, Ortega-Sanchez IR, Bi D, Ralston KJ, Rota PA, Waters-Montijo K, Lebaron CW. Measles outbreak in a highly vaccinated population, San Diego, 2008: role of the intentionally undervaccinated. Pediatrics 2010; 125: 747-55; PMID:20308208; http://dx.doi.org/10.1542/peds.2009-1653
   PubMed Web of Science ®Google Scholar
• Barskey AE, Glasser JW, LeBaron CW. Mumps resurgences in the United States: A historical perspective on unexpected elements. Vaccine 2009; 27: 6186-95; PMID:19815120; http://dx.doi.org/10.1016/j.vaccine.2009.06.109
   PubMed Web of Science ®Google Scholar
• Mauskopf J, Talbird S, Standaert B. Categorization of methods used in cost-effectiveness analyses of vaccination programs based on outcomes from dynamic transmission models. Expert Rev Pharmacoecon Outcomes Res 2012; 12: 357-71; PMID:22812559; http://dx.doi.org/10.1586/erp.12.11
   PubMed Web of Science ®Google Scholar
• Yi J, Anderson EJ. Rotavirus vaccination: short-term indirect herd protection, long-term uncertainty. Expert Rev Vaccines 2013; 12: 585-7; PMID:23750788; http://dx.doi.org/10.1586/erv.13.43
   PubMed Web of Science ®Google Scholar
• Carrion AF, Martin P. Viral hepatitis in the elderly. Am J Gastroenterol 2012; 107: 691-7; PMID:22290404; http://dx.doi.org/10.1038/ajg.2012.7
   PubMed Web of Science ®Google Scholar
• Boonacker CW, Broos PH, Sanders EA, Schilder AG, Rovers MM. Cost effectiveness of pneumococcal conjugate vaccination against acute otitis media in children: a review. Pharmacoeconomics 2011; 29: 199-211; PMID:21250759; http://dx.doi.org/10.2165/11584930-000000000-00000
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. Jama 2007; 298: 1772-8; PMID:17940232; http://dx.doi.org/10.1001/jama.298.15.1772
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Casey JR. Evolving microbiology and molecular epidemiology of acute otitis media in the pneumococcal conjugate vaccine era. Pediatr Infect Dis J 2007; 26: S12-6; PMID:18049375; http://dx.doi.org/10.1097/INF.0b013e318154b25d
   PubMed Web of Science ®Google Scholar
• Rozenbaum MH, Sanders EA, van Hoek AJ, Jansen AG, van der Ende A, van den Dobbelsteen G, Rodenburg GD, Hak E, Postma MJ. Cost effectiveness of pneumococcal vaccination among Dutch infants: economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines. Bmj 2010; 340: c2509; PMID:20519267; http://dx.doi.org/10.1136/bmj.c2509
   PubMed Web of Science ®Google Scholar
• Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006; 354: 1455-63; PMID:16598044; http://dx.doi.org/10.1056/NEJMoa051642
   PubMed Web of Science ®Google Scholar
• Munoz-Almagro C, Navarro-Torne A, Pallares R. Epidemiologic and clinical implications of second-generation pneumococcal conjugate vaccines. Curr Infect Dis Rep 2013; 15: 184-90; PMID:23381547; http://dx.doi.org/10.1007/s11908-013-0326-4
   PubMedGoogle Scholar
• Rozenbaum MH, Boersma C, Postma MJ, Hak E. Observed differences in invasive pneumococcal disease epidemiology after routine infant vaccination. Expert Rev Vaccines 2011; 10: 187-99; PMID:21332268; http://dx.doi.org/10.1586/erv.10.163
   PubMed Web of Science ®Google Scholar
• Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet 2011; 378: 1962-73; PMID:21492929; http://dx.doi.org/10.1016/S0140-6736(10)62225-8
   PubMed Web of Science ®Google Scholar
• Gounder PP, Bruce MG, Bruden DJ, Singleton RJ, Rudolph K, Hurlburt DA, Hennessy TW, Wenger J. Effect of the 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization by Streptococcus pneumoniae–Alaska, 2008-2012. J Infect Dis 2013; 209(8):1251-8; PMID:24273178
   PubMed Web of Science ®Google Scholar
• Zuccotti G, Mameli C, Daprai L, Garlaschi ML, Dilillo D, Bedogni G, Faccini M, Gramegna M, Torresani E. Serotype distribution and antimicrobial susceptibilities of nasopharyngeal isolates of Streptococcus pneumoniae from healthy children in the 13-valent pneumococcal conjugate vaccine era. Vaccine 32: 527-34; PMID:24342249; http://dx.doi.org/10.1016/j.vaccine.2013.12.003
   PubMed Web of Science ®Google Scholar
• Isaacman DJ, Strutton DR, Kalpas EA, Horowicz-Mehler N, Stern LS, Casciano R, Ciuryla V. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine. Clin Ther 2008; 30: 341-57; PMID:18343273; http://dx.doi.org/10.1016/j.clinthera.2008.02.003
   PubMed Web of Science ®Google Scholar
• Poletti P, Melegaro A, Ajelli M, Del Fava E, Guzzetta G, Faustini L, Scalia Tomba G, Lopalco P, Rizzo C, Merler S, et al. Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries. PLoS One 2013; 8: e60732; PMID:23613740; http://dx.doi.org/10.1371/journal.pone.0060732
   PubMed Web of Science ®Google Scholar
• Fairley CK, Miller E. Varicella-zoster virus epidemiology–a changing scene? J Infect Dis 1996; 174 Suppl 3: S314-9; PMID:8896538; http://dx.doi.org/10.1093/infdis/174.Supplement_3.S314
   PubMedGoogle Scholar
• Marin M, Watson TL, Chaves SS, Civen R, Watson BM, Zhang JX, Perella D, Mascola L, Seward JF. Varicella among adults: data from an active surveillance project, 1995–2005. J Infect Dis 2008; 197 Suppl 2: S94-S100; PMID:18419417; http://dx.doi.org/10.1086/522155
   PubMed Web of Science ®Google Scholar
• Berge JJ, Drennan DP, Jacobs RJ, Jakins A, Meyerhoff AS, Stubblefield W, Weinberg M. The cost of hepatitis A infections in American adolescents and adults in 1997. Hepatology 2000; 31: 469-73; PMID:10655272; http://dx.doi.org/10.1002/hep.510310229
   PubMed Web of Science ®Google Scholar
• Hepatitis A vaccine recommendations. Pediatrics 2007; 120: 189-99; PMID:17606579; http://dx.doi.org/10.1542/peds.2007-1088
   PubMed Web of Science ®Google Scholar
• Bonanni P, Boccalini S, Bechini A. Vaccination against hepatitis A in children: A review of the evidence. Ther Clin Risk Manag 2007; 3: 1071-6; PMID:18516263
   PubMedGoogle Scholar
• Srinivasa Rao AS, Chen MH, Pham BZ, Tricco AC, Gilca V, Duval B, Krahn MD, Bauch CT. Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis A. BMC Infect Dis 2006; 6: 174; PMID:17147828; http://dx.doi.org/10.1186/1471-2334-6-174
   PubMed Web of Science ®Google Scholar
• Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, Damaske B, Stefonek K, Barnes B, Patterson J, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998: Opportunities for prevention in the conjugate vaccine era. Jama 2001; 285: 1729-35; PMID:11277827; http://dx.doi.org/10.1001/jama.285.13.1729
   PubMed Web of Science ®Google Scholar
• Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. Jama 2005; 294: 797-802; PMID:16106004; http://dx.doi.org/10.1001/jama.294.7.797
   PubMed Web of Science ®Google Scholar
• Siedler A, Dettmann M. Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany. Hum Vaccin Immunother 2014; 10: 3594-600; PMID:25483695; http://dx.doi.org/10.4161/hv.34426
   PubMed Web of Science ®Google Scholar
• Tafuri S, Fortunato F, Cappelli MG, Cozza V, Bechini A, Bonanni P, Martinelli D, Prato R. Effectiveness of vaccination against varicella in children under 5 years in Puglia, Italy 2006–2012. Hum Vaccin Immunother 2015; 11: 214-9; PMID:25483538; http://dx.doi.org/10.4161/hv.36153
   PubMed Web of Science ®Google Scholar
• Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics 2008; 122: e744-51; PMID:18762511; http://dx.doi.org/10.1542/peds.2008-0567
   PubMed Web of Science ®Google Scholar
• Reynolds MA, Chaves SS, Harpaz R, Lopez AS, Seward JF. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. J Infect Dis 2008; 197 Suppl 2: S224-7; PMID:18419401; http://dx.doi.org/10.1086/522162
   PubMed Web of Science ®Google Scholar
• Schmid DS, Jumaan AO. Impact of varicella vaccine on varicella-zoster virus dynamics. Clin Microbiol Rev 2010; 23: 202-17; PMID:20065330; http://dx.doi.org/10.1128/CMR.00031-09
   PubMed Web of Science ®Google Scholar
• Shah SS, Wood SM, Luan X, Ratner AJ. Decline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella. Pediatr Infect Dis J 2010; 29: 199-204; PMID:19949362; http://dx.doi.org/10.1097/INF.0b013e3181bbf2a0
   PubMed Web of Science ®Google Scholar
• Yih WK, Brooks DR, Lett SM, Jumaan AO, Zhang Z, Clements KM, Seward JF. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998–2003. BMC Public Health 2005; 5: 68; PMID:15960856; http://dx.doi.org/10.1186/1471-2458-5-68
   PubMed Web of Science ®Google Scholar
• Brisson M, Edmunds WJ. Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs. Med Decis Making 2006; 26: 434-46; PMID:16997923; http://dx.doi.org/10.1177/0272989X06290485
   PubMed Web of Science ®Google Scholar
• Gil-Prieto R, Walter S, Gonzalez-Escalada A, Garcia-Garcia L, Marin-Garcia P, Gil-de-Miguel A. Different vaccination strategies in Spain and its impact on severe varicella and zoster. Vaccine 2014; 32: 277-83; PMID:24275483; http://dx.doi.org/10.1016/j.vaccine.2013.11.008
   PubMed Web of Science ®Google Scholar
• Russell ML, Schopflocher DP, Svenson L, Virani SN. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect 2007; 135: 908-13; PMID:17291380; http://dx.doi.org/10.1017/S0950268807007893
   PubMed Web of Science ®Google Scholar
• Stein M, Cohen R, Bromberg M, Tasher D, Shohat T, Somekh E. Herpes zoster in a partially vaccinated pediatric population in central Israel. Pediatr Infect Dis J 2012; 31: 906-9; PMID:22627868; http://dx.doi.org/10.1097/INF.0b013e31825d33f9
   PubMed Web of Science ®Google Scholar
• Tanuseputro P, Zagorski B, Chan KJ, Kwong JC. Population-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination program. Vaccine 2011; 29: 8580-4; PMID:21939721; http://dx.doi.org/10.1016/j.vaccine.2011.09.024
   PubMed Web of Science ®Google Scholar
• Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, Seward JF. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J 2009; 28: 954-9; PMID:19536039; http://dx.doi.org/10.1097/INF.0b013e3181a90b16
   PubMed Web of Science ®Google Scholar
• Hales CM, Harpaz R, Joesoef MR, Bialek SR. Examination of links between herpes zoster incidence and childhood varicella vaccination. Ann Intern Med 2013; 159: 739-45; PMID:24297190; http://dx.doi.org/10.7326/0003-4819-159-11-201312030-00006
   PubMed Web of Science ®Google Scholar
• Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992–2002. J Infect Dis 2005; 191: 2002-7; PMID:15897984; http://dx.doi.org/10.1086/430325
   PubMed Web of Science ®Google Scholar
• Leung J, Harpaz R, Molinari NA, Jumaan A, Zhou F. Herpes zoster incidence among insured persons in the United States, 1993–2006: evaluation of impact of varicella vaccination. Clin Infect Dis 2011; 52: 332-40; PMID:21217180; http://dx.doi.org/10.1093/cid/ciq077
   PubMed Web of Science ®Google Scholar
• Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H. Incidence of herpes zoster, 1997–2002. Epidemiol Infect 2005; 133: 245-53; PMID:15816149; http://dx.doi.org/10.1017/S095026880400281X
   PubMed Web of Science ®Google Scholar
• Carville KS, Riddell MA, Kelly HA. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia. Vaccine 2010; 28: 2532-8; PMID:20117265; http://dx.doi.org/10.1016/j.vaccine.2010.01.036
   PubMed Web of Science ®Google Scholar
• Heywood AE, Wang H, Macartney KK, McIntyre P. Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study. Bull World Health Organ 2014; 92: 593-604; PMID:25177074; http://dx.doi.org/10.2471/BLT.13.132142
   PubMed Web of Science ®Google Scholar
• Jardine A, Conaty SJ, Vally H. Herpes zoster in Australia: evidence of increase in incidence in adults attribu to varicella immunization? Epidemiol Infect 2011; 139: 658-65; PMID:20727248; http://dx.doi.org/10.1017/S0950268810001949
   PubMed Web of Science ®Google Scholar
• Ladhani SN, Slack MP, Andrews NJ, Waight PA, Borrow R, Miller E. Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales. Emerg Infect Dis 2013; 19: 61-8; PMID:23259937; http://dx.doi.org/10.3201/eid1901.120741
   PubMed Web of Science ®Google Scholar
• Weinmann S, Chun C, Schmid DS, Roberts M, Vandermeer M, Riedlinger K, Bialek SR, Marin M. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005–2009. J Infect Dis 2013; 208: 1859-68; PMID:23922376; http://dx.doi.org/10.1093/infdis/jit405
   PubMed Web of Science ®Google Scholar
• Chao DY, Chien YZ, Yeh YP, Hsu PS, Lian IB. The incidence of varicella and herpes zoster in Taiwan during a period of increasing varicella vaccine coverage, 2000–2008. Epidemiol Infect 2012; 140: 1131-40; PMID:21906410; http://dx.doi.org/10.1017/S0950268811001786
   PubMed Web of Science ®Google Scholar
• Goldman GS. Incidence of herpes zoster among children and adolescents in a community with moderate varicella vaccination coverage. Vaccine 2003; 21: 4243-9; PMID:14505905; http://dx.doi.org/10.1016/S0264-410X(03)00459-6
   PubMed Web of Science ®Google Scholar
• Goldman GS. Universal varicella vaccination: efficacy trends and effect on herpes zoster. Int J Toxicol 2005; 24: 205-13; PMID:16126614; http://dx.doi.org/10.1080/10915810591000659
   PubMed Web of Science ®Google Scholar
• Kelly HA, Grant KA, Gidding H, Carville KS. Decreased varicella and increased herpes zoster incidence at a sentinel medical deputising service in a setting of increasing varicella vaccine coverage in Victoria, Australia, 1998 to 2012. Euro Surveill 2014; 19
   Google Scholar
• Patel MS, Gebremariam A, Davis MM. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States. Infect Control Hosp Epidemiol 2008; 29: 1157-63; PMID:18999945; http://dx.doi.org/10.1086/591975
   PubMed Web of Science ®Google Scholar
• Wu PY, Wu HD, Chou TC, Sung FC. Varicella vaccination alters the chronological trends of herpes zoster and varicella. PLoS One 2013; 8: e77709; PMID:24204928; http://dx.doi.org/10.1371/journal.pone.0077709
   PubMed Web of Science ®Google Scholar
• Purdy KW, Hay JW, Botteman MF, Ward JI. Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis. Clin Infect Dis 2004; 39: 20-8; PMID:15206048; http://dx.doi.org/10.1086/421091
   PubMed Web of Science ®Google Scholar
• Caro JJ, Getsios D, El-Hadi W, Payne K, O'Brien JA. Pertussis immunization of adolescents in the United States: an economic evaluation. Pediatr Infect Dis J 2005; 24: S75-82; PMID:15876932; http://dx.doi.org/10.1097/01.inf.0000160918.72953.51
   PubMedGoogle Scholar
• Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010; 17: 1055-65; PMID:20463105; http://dx.doi.org/10.1128/CVI.00131-10
   PubMed Web of Science ®Google Scholar
• Cherry JD. Why do pertussis vaccines fail? Pediatrics 2012; 129: 968-70; PMID:22529282; http://dx.doi.org/10.1542/peds.2011-2594
   PubMed Web of Science ®Google Scholar
• John TJ, Samuel R. Herd immunity and herd effect: new insights and definitions. Eur J Epidemiol 2000; 16: 601-6; PMID:11078115; http://dx.doi.org/10.1023/A:1007626510002
   PubMed Web of Science ®Google Scholar
• Moulton LH, Chung S, Croll J, Reid R, Weatherholtz RC, Santosham M. Estimation of the indirect effect of Haemophilus influenzae type b conjugate vaccine in an American Indian population. Int J Epidemiol 2000; 29: 753-6; PMID:10922355; http://dx.doi.org/10.1093/ije/29.4.753
   PubMed Web of Science ®Google Scholar
• Atkins KE, Shim E, Pitzer VE, Galvani AP. Impact of rotavirus vaccination on epidemiological dynamics in England and Wales. Vaccine 2012; 30: 552-64; PMID:22133508; http://dx.doi.org/10.1016/j.vaccine.2011.11.064
   PubMed Web of Science ®Google Scholar
• Tu HA, Rozenbaum MH, de Boer PT, Noort AC, Postma MJ. An update of “Cost-effectiveness of rotavirus vaccination in the Netherlands: the results of a Consensus Rotavirus Vaccine model”. BMC Infect Dis 2013; 13: 54; PMID:23363553; http://dx.doi.org/10.1186/1471-2334-13-54
   PubMed Web of Science ®Google Scholar
• Rozenbaum MH, Mangen MJ, Giaquinto C, Wilschut JC, Hak E, Postma MJ. Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model. BMC Public Health 2011; 11: 462; PMID:21663620; http://dx.doi.org/10.1186/1471-2458-11-462
   PubMed Web of Science ®Google Scholar
• Standaert B, Gomez JA, Raes M, Debrus S, Velazquez FR, Postma MJ. Impact of rotavirus vaccination on hospitalisations in Belgium: comparing model predictions with observed data. PLoS One 2013; 8: e53864; PMID:23349754; http://dx.doi.org/10.1371/journal.pone.0053864
   PubMed Web of Science ®Google Scholar
• Shim E, Galvani AP. Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination. Vaccine 2009; 27: 4025-30; PMID:19389452; http://dx.doi.org/10.1016/j.vaccine.2009.04.030
   PubMed Web of Science ®Google Scholar
• Aballea S, Millier A, Quilici S, Caroll S, Petrou S, Toumi M. A critical literature review of health economic evaluations of rotavirus vaccination. Hum Vaccin Immunother 2013; 9: 1272-88; PMID:23571226; http://dx.doi.org/10.4161/hv.24253
   PubMed Web of Science ®Google Scholar
• Lopman BA, Curns AT, Yen C, Parashar UD. Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis 2011; 204: 980-6; PMID:21878425; http://dx.doi.org/10.1093/infdis/jir492
   PubMed Web of Science ®Google Scholar
• Marty R, Roze S, Bresse X, Largeron N, Smith-Palmer J. Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe. BMC Cancer 2013; 13: 10; PMID:23298365; http://dx.doi.org/10.1186/1471-2407-13-10
   PubMed Web of Science ®Google Scholar
• Sando N, Kofoed K, Zachariae C, Fouchard J. A Reduced National Incidence of Anogenital Warts in Young Danish Men and Women after Introduction of a National Quadrivalent Human Papillomavirus Vaccination Programme for Young Women - An Ecological Study. Acta Derm Venereol 2014; 94(3):288-92.
   PubMed Web of Science ®Google Scholar
• Brisson M, Laprise JF, Drolet M, Van de Velde N, Franco EL, Kliewer EV, Ogilvie G, Deeks SL, Boily MC. Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study. Vaccine 2013; 31: 3863-71; PMID:23830974; http://dx.doi.org/10.1016/j.vaccine.2013.06.064
   PubMed Web of Science ®Google Scholar
• Van de Velde N, Brisson M, Boily MC. Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis. Vaccine 2010; 28: 5473-84; PMID:20573580; http://dx.doi.org/10.1016/j.vaccine.2010.05.056
   PubMed Web of Science ®Google Scholar
• Elbasha EH, Dasbach EJ, Insinga RP. Model for assessing human papillomavirus vaccination strategies. Emerg Infect Dis 2007; 13: 28-41; PMID:17370513; http://dx.doi.org/10.3201/eid1301.060438
   PubMed Web of Science ®Google Scholar
• Kahn JA, Brown DR, Ding L, Widdice LE, Shew ML, Glynn S, Bernstein DI. Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction. Pediatrics 2012; 130: e249-56; PMID:22778297; http://dx.doi.org/10.1542/peds.2011-3587
   PubMed Web of Science ®Google Scholar
• Bauch CT, Rao AS, Pham BZ, Krahn M, Gilca V, Duval B, Chen MH, Tricco AC. A dynamic model for assessing universal Hepatitis A vaccination in Canada. Vaccine 2007; 25: 1719-26; PMID:17229493; http://dx.doi.org/10.1016/j.vaccine.2006.11.020
   PubMed Web of Science ®Google Scholar
• Taranger J, Trollfors B, Bergfors E, Knutsson N, Sundh V, Lagergard T, Lind-Brandberg L, Zackrisson G, White J, Cicirello H, et al. Mass vaccination of children with pertussis toxoid–decreased incidence in both vaccinated and nonvaccinated persons. Clin Infect Dis 2001; 33: 1004-10; PMID:11528572; http://dx.doi.org/10.1086/322639
   PubMed Web of Science ®Google Scholar
• Lee GM, Murphy TV, Lett S, Cortese MM, Kretsinger K, Schauer S, Lieu TA. Cost effectiveness of pertussis vaccination in adults. Am J Prev Med 2007; 32: 186-193; PMID:17296470; http://dx.doi.org/10.1016/j.amepre.2006.10.016
   PubMed Web of Science ®Google Scholar